Category: Medications - Page 4

The FDA's 2023-2025 changes to generic drug approvals prioritize U.S.-made medications to prevent shortages. Learn how the new pilot program speeds up approvals, impacts prices, and affects drug availability.

6 December 2025

Ali Wilkin

Authorized Generic Pricing: Why They Cost Less Than Brand Name Drugs

Authorized generics are identical to brand-name drugs but cost significantly less because they skip marketing and branding expenses. Learn how they work, why they're cheaper, and how to get them.

5 December 2025

Ali Wilkin

When to Seek Medical Help for a Suspected Drug Interaction

Learn when to seek emergency help for drug interactions - from life-threatening symptoms like seizures and breathing trouble to warning signs that need urgent medical attention within 24 hours.

4 December 2025

Ali Wilkin

Keeping a Medication Journal: Tracking Your Response to Generic Medications

Keep a simple medication journal when switching to generic drugs to track side effects, effectiveness, and manufacturer changes - especially for thyroid, blood thinners, or seizure meds. Small differences can impact how you feel.

4 December 2025

Ali Wilkin

DOAC Dosing in Obesity: What You Need to Know About Efficacy, Safety, and Side Effects

Learn how DOACs like apixaban, rivaroxaban, dabigatran, and edoxaban work in obese patients. Find out which ones are safe, which to avoid, and why standard doses still work-even for extreme obesity.

3 December 2025

Ali Wilkin

Antitrust Issues in Generic Substitution: How Big Pharma Blocks Cheaper Drugs

Big pharma is using legal loopholes to block cheaper generic drugs by pulling older versions off the market. Learn how product hopping, REMS abuse, and court rulings are affecting drug prices and what’s being done to stop it.

1 December 2025

Ali Wilkin

Statistical Analysis in BE Studies: How to Calculate Power and Sample Size Correctly

Learn how to correctly calculate power and sample size for bioequivalence studies to avoid costly failures. Understand CV%, GMR, regulatory requirements, and tools used by industry professionals.

1 December 2025

Ali Wilkin

Mood and Behavioral Changes from Corticosteroids: Understanding the Psychosis Risk

Corticosteroids can trigger mood swings, mania, and even psychosis - especially at high doses or in older adults. Learn the signs, risks, and what to do if you or a loved one experiences psychiatric side effects.

29 November 2025

Ali Wilkin

European Generic Markets: Regulatory Approaches Across the EU in 2025

The EU's generic drug system uses four approval paths with major 2025 reforms to speed up access. Learn how bioequivalence rules, national differences, and new regulations impact market entry and pricing.